Biogen Inc.
BIIB
$210.73
-$1.77-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.31% | 1.23% | 2.22% | 4.77% | 3.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.31% | 1.23% | 2.22% | 4.77% | 3.36% |
| Cost of Revenue | -3.78% | -20.58% | -19.37% | -18.21% | -17.30% |
| Gross Profit | 1.50% | 9.35% | 10.08% | 13.58% | 11.49% |
| SG&A Expenses | 7.48% | 3.70% | 1.99% | 4.97% | -3.01% |
| Depreciation & Amortization | 24.34% | 26.62% | 31.20% | 38.14% | 52.13% |
| Other Operating Expenses | 15.65% | 24.06% | 14.07% | 10.25% | 11.47% |
| Total Operating Expenses | 3.93% | 0.75% | -0.08% | 0.68% | -3.44% |
| Operating Income | -9.19% | 2.53% | 8.44% | 16.30% | 26.82% |
| Income Before Tax | -43.74% | -7.38% | -18.34% | -0.11% | 36.82% |
| Income Tax Expenses | -33.83% | -8.06% | -3.73% | 1.30% | 70.95% |
| Earnings from Continuing Operations | -45.47% | -7.26% | -20.79% | -0.37% | 32.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.47% | -7.26% | -20.79% | -0.41% | 32.10% |
| EBIT | -9.19% | 2.53% | 8.44% | 16.30% | 26.82% |
| EBITDA | -4.42% | 4.73% | 9.96% | 17.32% | 27.53% |
| EPS Basic | -45.79% | -7.87% | -21.28% | -1.04% | 31.43% |
| Normalized Basic EPS | -9.56% | 3.64% | 11.83% | 20.88% | 27.65% |
| EPS Diluted | -45.97% | -7.95% | -21.24% | -1.01% | 31.58% |
| Normalized Diluted EPS | -9.76% | 3.60% | 11.93% | 20.99% | 27.75% |
| Average Basic Shares Outstanding | 0.72% | 0.67% | 0.64% | 0.60% | 0.60% |
| Average Diluted Shares Outstanding | 0.92% | 0.72% | 0.53% | 0.50% | 0.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |